Reuters logo
BRIEF-Horizon Pharma reports Q3 Non-GAAP earnings per share $0.26
2017年11月6日 / 下午1点13分 / 15 天前

BRIEF-Horizon Pharma reports Q3 Non-GAAP earnings per share $0.26

Nov 6 (Reuters) - Horizon Pharma Plc:

* Horizon Pharma plc announces third-quarter and year-to-date 2017 results

* Q3 sales $271.6 million versus I/B/E/S view $259.7 million

* Q3 earnings per share view $0.22 -- Thomson Reuters I/B/E/S

* Sees FY 2017 sales $1.03 billion to $1.05 billion

* Q3 GAAP loss per share $0.39

* Q3 Non-GAAP earnings per share $0.26

* Horizon Pharma plc says sees FY 2017 ‍adjusted EBITDA guidance range of $350 million to $375 million from $340 million to $375 million

* Horizon Pharma says sees Krystexxa 2018 net sales up more than 50 percent​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below